Does comorbidity burden explain the higher COVID-19 mortality risk among men? A retrospective cross-sectional analysis of a well-defined cohort of patients in Bronx, New York.

Aastha VasaMaya KiniJoel NeugartenEran BellinLadan Golestaneh

Published in: BMJ open (2022)

Higher male mortality risk during the COVID-19 period despite adjustment for comorbidity supports the role of innate physiological susceptibility to COVID-19 death. Attenuation of higher male risk towards the null after adjustment for severity of lung disease in hospitalised COVID-19+ patients further supports the role of higher severity of COVID-19 pneumonia in men.

Keyphrases

sars cov
coronavirus disease
cross sectional
respiratory syndrome coronavirus
immune response
end stage renal disease
newly diagnosed
middle aged
intensive care unit
respiratory failure
mechanical ventilation